TP0502-Pharmaco-Scintigraphic-Study and Amendment

NCT02306785 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

26

Enrollment

INDUSTRY

Sponsor class

Conditions

Ulcerative Colitis

Interventions

DRUG: TP05 Coating D
DRUG: TP05 Coating E
DRUG: TP05 Coating H

Sponsor

Tillotts Pharma AG